Abstract
The most dreaded complication with percutaneous coronary intervention with stents,
either bare-metal or drug-eluting stents is stent thrombosis (ST) and it has a significant
detrimental effect on the outcome for the patient. The initial attempts at intervention
with bare-metal stents had much higher rates of ST compared with what is currently
prevailing in the modern interventional world. Significant changes with respect to
the stent technology, pharmacology, and most importantly our understanding of this
phenomenon have decreased the risk of ST. There are many factors that can be performed
to minimize the risk of ST and this review will describe the incidence, pathophysiology,
and contributing risk factors to ST.
Keywords
stent thrombosis - bioresorbable vascular scaffolds - drug-eluting stents - bare-metal
stents - dual antiplatelet therapy
